CXCL9 and ovarian cancer: Thus, activation of the adaptive immune response seems to be the major mechanism behind the protective nature of CXCL9 in ovarian cancer, possibly more important than chemotactic retention of CXCR3-positive tumour cells in the primary tumour as proposed before [26].